Zeiss Gets FDA Clearance for CLARUS 700

By

A retinal scan taken with
Zeiss' Clarus 700 and
enhanced by True Color
Ultra-widefield technology. Image courtesy of Zeiss. 

DUBLIN, Calif.—The Zeiss Medical Technology Segment of Zeiss announced that it has received 510(K) clearance from the FDA for the CLARUS 700, high-definition, ultra-widefield imaging system for advanced care specialists. CLARUS 700 is the first high-resolution ultra-widefield imaging with True Color and a complete range of fundus imaging modalities, including fluorescein angiography (FA), according to Zeiss. Ultra-widefield fluorescein angiography helps eyecare specialists identify earlier more severe forms of diabetic retinopathy like neovascularization and retinal diseases such as uveitis, choroidal masses, retinal tears, detachments, and peripheral ischemia. The high-resolution and high contrast images of the FA from the CLARUS 700 allow clinicians to capture the smallest details from the macula in early phase to the periphery in late phase of FA, Zeiss said.